We aim to educate those curious about psychedelics find current information. Medicine: https://www.hopkinspsychedelic.org

CORE BENEFITS IN PALLIATIVE SETTINGS

Sustained Outcomes: Single-dose interventions have shown to maintain antidepressant and anxiolytic effects for months, and in some cases, up to 4.5 years later.

• Existential Relief: Research from institutions like Johns Hopkins suggests psychedelics can significantly reduce the fear of death, often through “mystical-type” experiences that foster a sense of interconnectedness and peace.
• PTSD:Sustained Outcomes: Single-dose interventions have shown to maintain CHRONIC DEPRESSION: antidepressant and anxiolytic effects for months, in some cases up to 4.5 years.
• PAIN: Beyond emotional support, psilocybin is being studied for its potential to reduce chronic pain by interacting with serotonin receptors and lowering systemic inflammation.